Cargando…
D-2-Hydroxyglutarate does not mimic all the IDH mutation effects, in particular the reduced etoposide-triggered apoptosis mediated by an alteration in mitochondrial NADH
Somatic mutations in isocitrate dehydrogenase (IDH)-1 and -2 have recently been described in glioma. This mutation leads to a neomorphic enzymatic activity as the conversion of isocitrate to alpha ketoglutarate (αKG) is replaced by the conversion of αKG to D-2-hydroxyglutarate (D-2HG) with NADPH oxi...
Autores principales: | Oizel, K, Gratas, C, Nadaradjane, A, Oliver, L, Vallette, F M, Pecqueur, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4385911/ https://www.ncbi.nlm.nih.gov/pubmed/25811801 http://dx.doi.org/10.1038/cddis.2015.13 |
Ejemplares similares
-
Targeting Metabolism to Induce Cell Death in Cancer Cells and Cancer Stem Cells
por: Pecqueur, Claire, et al.
Publicado: (2013) -
Clinical usefulness of 2-hydroxyglutarate as a biomarker in IDH-mutant chondrosarcoma
por: Nakagawa, Makoto, et al.
Publicado: (2022) -
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas
por: Riviere-Cazaux, Cecile, et al.
Publicado: (2023) -
Radiation-induced PGE(2) sustains human glioma cell growth and survival through EGF signaling
por: Brocard, Emeline, et al.
Publicado: (2015) -
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients
por: Choi, Changho, et al.
Publicado: (2012)